Mugittu, K., Priotto, G., Guthmann, J.-P., Kiguli, J., Adjuik, M., Snounou, G., Beck, H.-P., Mshinda, H., Olliaro, P. L. and Taylor, W. R. J. (2007) Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment. Tropical medicine & international health : TM & IH, 12 (2). pp. 219-23. ISSN 1360-2276
Molecular_genotyping_in_a_Malaria_Treatment.pdf - Published Version
Restricted to Affiliated users only
Available under License Creative Commons Attribution Non-commercial.
Polymerase chain reaction (PCR) genotyping of malaria parasites in drug efficacy trials helps differentiate reinfections from recrudescences. A combination therapy trial of one (n = 115) or three (n = 117) days artesunate (1AS, 3AS 4 mg/kg/day) plus sulphadoxine-pyrimethamine (SP) vs. SP alone (n = 153) was conducted in Mbarara, a mesoendemic area of western Uganda. All paired recurrent Plasmodium falciparum parasitaemias on days 7, 14, 21 and 28 post-treatment were genotyped by PCR amplification and analysis of glutamate-rich protein (glurp) and merozoite surface proteins (msp) 1 and 2 genes to distinguish recrudescent from new infections. A total of 156 (1AS = 61, 3AS = 35, SP alone = 60) of 199 paired recurrent samples were successfully analysed and were resolved as 79 recrudescences (1AS = 32, 3AS = 8, SP = 39) and 77 as new infections (1AS = 29, 3AS = 27, SP = 21). The ratios of proportions of new to recrudescent infections were 0.2, 0.9, 1.4 and 1.9 on days 7, 14, 21 and 28, respectively (P < 0.001, chi(2) test for linear trend). Unexpected high new infection rates were observed early in follow-up on days 7 [5/26 (19.2%)] and 14 [24/51 (47.1%)]. These results impact significantly on resistance monitoring and point to the value of genotyping all recurrent infections in antimalarial trials.
|Keywords:||Molecular genotyping,malaria treatment, infections, parasites, drug efficacy trials, sulphadoxine-pyrimethamine, Plasmodium falciparum parasitaemias,|
|Subjects:||Malaria > Diagnosis & treatment|
|Divisions:||Ifakara Health Institute > Biomedical|
|Depositing User:||Mr Joseph Madata|
|Date Deposited:||13 Jul 2012 12:23|
|Last Modified:||16 Aug 2012 15:57|
Actions (login required)
Downloads per month over past year